{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T06:10:31Z","timestamp":1783923031637,"version":"3.55.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013254","name":"National College Students Innovation and Entrepreneurship Training Program","doi-asserted-by":"publisher","award":["202510346019"],"award-info":[{"award-number":["202510346019"]}],"id":[{"id":"10.13039\/501100013254","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bcp.2026.118099","type":"journal-article","created":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T15:04:58Z","timestamp":1779548698000},"page":"118099","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P1","title":["Butein suppresses pancreatic cancer progression by downregulating CDK2 and disrupting CDK2\/CyclinA2 interaction"],"prefix":"10.1016","volume":"251","author":[{"given":"Mengting","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjiang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehua","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiping","family":"Mou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueni","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7330-0467","authenticated-orcid":false,"given":"Xinbing","family":"Sui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10485","key":"10.1016\/j.bcp.2026.118099_b0005","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S0140-6736(25)00261-2","article-title":"Pancreatic cancer","volume":"405","author":"Stoop","year":"2025","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.bcp.2026.118099_b0010","article-title":"Advances in pancreatic cancer early diagnosis, prevention, and treatment: the past, the present, and the future","volume":"76","author":"Mannucci","year":"2026","journal-title":"CA Cancer J. Clin."},{"issue":"18","key":"10.1016\/j.bcp.2026.118099_b0015","doi-asserted-by":"crossref","first-page":"4504","DOI":"10.3390\/ijms20184504","article-title":"Chemoresistance in Pancreatic Cancer","volume":"20","author":"Zeng","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.118099_b0020","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.drup.2015.10.002","article-title":"Gemcitabine resistance in pancreatic ductal adenocarcinoma","volume":"23","author":"Binenbaum","year":"2015","journal-title":"Drug Resist. Updat."},{"issue":"3","key":"10.1016\/j.bcp.2026.118099_b0025","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrc2602","article-title":"Cell cycle, CDKs and cancer: a changing paradigm","volume":"9","author":"Malumbres","year":"2009","journal-title":"Nat. Rev. Cancer"},{"issue":"10","key":"10.1016\/j.bcp.2026.118099_b0030","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.3390\/ijms19103219","article-title":"The Emerging Role of Cyclin-Dependent Kinases (CDKs) in Pancreatic Ductal Adenocarcinoma","volume":"19","author":"Garc\u00eda-Reyes","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2026.118099_b0035","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/s41467-022-28265-0","article-title":"Cyclin B\/CDK1 and Cyclin A\/CDK2 phosphorylate DENR to promote mitotic protein translation and faithful cell division","volume":"13","author":"Clemm von Hohenberg","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bcp.2026.118099_b0040","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1038\/s41467-022-30264-0","article-title":"Inhibition of the CDK2 and Cyclin a complex leads to autophagic degradation of CDK2 in cancer cells","volume":"13","author":"Zhang","year":"2022","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.bcp.2026.118099_b0045","first-page":"446","article-title":"INX-315, a Selective CDK2 Inhibitor","volume":"14","author":"Dietrich","year":"2024","journal-title":"Induces Cell Cycle Arrest and Senescence in Solid Tumors, Cancer Discov."},{"issue":"7","key":"10.1016\/j.bcp.2026.118099_b0050","article-title":"Targeting CDK2 Confers Vulnerability to Lenvatinib Via Driving Senescence in Anaplastic Thyroid Cancer","volume":"12","author":"Ma","year":"2025","journal-title":"Adv Sci (weinh)"},{"issue":"3","key":"10.1016\/j.bcp.2026.118099_b0055","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","article-title":"Natural Products as sources of New Drugs over the Nearly four decades from 01\/1981 to 09\/2019","volume":"83","author":"Newman","year":"2020","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bcp.2026.118099_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155634","article-title":"Anticancer diterpenes of african natural products: Mechanistic pathways and preclinical developments","volume":"129","author":"Bangay","year":"2024","journal-title":"Phytomedicine"},{"issue":"9","key":"10.1016\/j.bcp.2026.118099_b0065","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1002\/ptr.7099","article-title":"Natural products: a lead for drug discovery and development","volume":"35","author":"Chopra","year":"2021","journal-title":"Phytother. Res."},{"issue":"7","key":"10.1016\/j.bcp.2026.118099_b0070","first-page":"769","article-title":"Paclitaxel anti-cancer therapeutics: from discovery to clinical use","volume":"23","author":"Yu","year":"2025","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.bcp.2026.118099_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113639","article-title":"Camptothecin's journey from discovery to WHO Essential Medicine: Fifty years of promise","volume":"223","author":"Khaiwa","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"12","key":"10.1016\/j.bcp.2026.118099_b0080","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1080\/17460441.2024.2436908","article-title":"Advances in chalcone-based anticancer therapy: mechanisms, preclinical advances, and future perspectives","volume":"19","author":"Chowdhary","year":"2024","journal-title":"Expert Opin. Drug Discov."},{"issue":"4","key":"10.1016\/j.bcp.2026.118099_b0085","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1007\/s12011-024-04331-0","article-title":"Pharmacological Inhibition of TXNRD1 by a Small Molecule Flavonoid Butein Overcomes Cisplatin Resistance in Lung Cancer Cells","volume":"203","author":"Yang","year":"2025","journal-title":"Biol. Trace Elem. Res."},{"issue":"6","key":"10.1016\/j.bcp.2026.118099_b0090","first-page":"836","article-title":"Effect of Butein, a Plant Polyphenol, on Apoptosis and Necroptosis of Prostate Cancer Cells in 2D and 3D Cultures","volume":"15","author":"Lee","year":"2025","journal-title":"Life (basel)"},{"issue":"7","key":"10.1016\/j.bcp.2026.118099_b0095","doi-asserted-by":"crossref","first-page":"6038","DOI":"10.3390\/ijms24076038","article-title":"Butein Inhibits Cell Growth by Blocking the IL-6\/IL-6R\u03b1 Interaction in Human Ovarian Cancer and by Regulation of the IL-6\/STAT3\/FoxO3a Pathway","volume":"24","author":"Park","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"39","key":"10.1016\/j.bcp.2026.118099_b0100","doi-asserted-by":"crossref","first-page":"6527","DOI":"10.3748\/wjg.v27.i39.6527","article-title":"Therapeutic resistance in pancreatic ductal adenocarcinoma: current challenges and future opportunities","volume":"27","author":"Jain","year":"2021","journal-title":"World J. Gastroenterol."},{"issue":"10","key":"10.1016\/j.bcp.2026.118099_b0105","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.3390\/cancers14102486","article-title":"Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma: a Physiopathologic and Pharmacologic Review","volume":"14","author":"Koltai","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bcp.2026.118099_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107099","article-title":"Natural products for combating multidrug resistance in cancer","volume":"202","author":"Chen","year":"2024","journal-title":"Pharmacol. Res."},{"issue":"10","key":"10.1016\/j.bcp.2026.118099_b0115","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1111\/bph.70014","article-title":"Natural products and cancer: from drug discovery to prevention and therapy","volume":"182","author":"Izzo","year":"2025","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118099_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115630","article-title":"Curing childhood cancer the \u201cNatural\u201d way: Nature as the source of chemotherapy agents","volume":"213","author":"Al-Antary","year":"2023","journal-title":"Biochem. Pharmacol."},{"issue":"13","key":"10.1016\/j.bcp.2026.118099_b0125","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.phymed.2015.08.015","article-title":"Potential of butein, a tetrahydroxychalcone to obliterate cancer","volume":"22","author":"Padmavathi","year":"2015","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bcp.2026.118099_b0130","doi-asserted-by":"crossref","unstructured":"B. Hu, S. Mitra J Fau - van den Heuvel, G.H. van den Heuvel S Fau - Enders, G.H. Enders, S and G2 phase roles for Cdk2 revealed by inducible expression of a dominant-negative mutant in human cells, Mol Cell Biol. 21 (8) (2001) 2755-2766.","DOI":"10.1128\/MCB.21.8.2755-2766.2001"},{"issue":"31","key":"10.1016\/j.bcp.2026.118099_b0135","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1038\/onc.2008.74","article-title":"Cyclin A\/cdk2 coordinates centrosomal and nuclear mitotic events","volume":"27","author":"De Boer","year":"2008","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.bcp.2026.118099_b0140","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1158\/0008-5472.CAN-14-1494","article-title":"CDK2 Inhibition Causes Anaphase catastrophe in Lung Cancer through the Centrosomal Protein CP110","volume":"75","author":"Hu","year":"2015","journal-title":"Cancer Res."},{"issue":"14","key":"10.1016\/j.bcp.2026.118099_b0145","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1158\/1078-0432.CCR-20-4781","article-title":"Global Phosphoproteomics Reveal CDK suppression as a Vulnerability to KRas Addiction in Pancreatic Cancer","volume":"27","author":"Kazi","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2026.118099_b0150","doi-asserted-by":"crossref","unstructured":"E. Macias, P.L. Kim Y Fau - Miliani de Marval, A. Miliani de Marval Pl Fau - Klein-Szanto, M.L. Klein-Szanto A Fau - Rodriguez-Puebla, M.L. Rodriguez-Puebla, Cdk2 deficiency decreases ras\/CDK4-dependent malignant progression, but not myc-induced tumorigenesis, Cancer Res. 67 (20) (2007) 9713-9720.","DOI":"10.1158\/0008-5472.CAN-07-2119"},{"issue":"3","key":"10.1016\/j.bcp.2026.118099_b0155","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S1535-6108(03)00053-9","article-title":"Proliferation of cancer cells despite CDK2 inhibition","volume":"3","author":"Tetsu","year":"2003","journal-title":"Cancer Cell"},{"issue":"7155","key":"10.1016\/j.bcp.2026.118099_b0160","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/nature06046","article-title":"Cdk1 is sufficient to drive the mammalian cell cycle","volume":"448","author":"Santamar\u00eda","year":"2007","journal-title":"Nature"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522600434X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522600434X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T05:34:18Z","timestamp":1783920858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000629522600434X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":32,"alternative-id":["S000629522600434X"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118099","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Butein suppresses pancreatic cancer progression by downregulating CDK2 and disrupting CDK2\/CyclinA2 interaction","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118099","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"118099"}}